Lilly Gets Second EUA, For Baricitinib In COVID-19 Patients

 
• By Joseph Haas
  
Coronavirus globe
Lilly's second EUA for a COVID-19 therapy covers Olumiant in hospitalized patients
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip